أرسل هذا في رسالة قصيرة: Health-related quality-of-life in a randomized phase III first-line study of gefitinib versus carboplatin/paclitaxel in clinically selected patients from Asia with advanced NSCLC (IPASS)

 __   __     ___       _____     ___      ______  
 \ \\/ //   / _ \\    / ___//   / _ \\   /_   _// 
  \   //   | / \ ||   \___ \\  / //\ \\  `-| |,-  
  / . \\   | \_/ ||   /    // |  ___  ||   | ||   
 /_//\_\\   \___//   /____//  |_||  |_||   |_||   
 `-`  --`   `---`   `-----`   `-`   `-`    `-`'